Infant mortality in U.S. rose last year for first time in decades: CDC

APPhoto/EricGayTheU.S.infantmortalityraterose3%lastyear—thelargestincreaseintwodecades,accordingtoth 1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS




hotspot

author：entertainment    Page View：82414
Adam's take main illustration
Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

advertisement

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Kidney transplant patients stopped immunosuppressants in trial
Next article： BioMarin wins approval for gene therapy to treat hemophilia A